Bridgewest Perth Pharma

Bridgewest Perth Pharma is a global pharmaceutical company wholly owned by the private investment firm Bridgewest Group. It operates through two divisions: NovaCina (the company’s CDMO) and LumaCina (the company’s pharmaceutical marketing and supply division). Bridgewest Perth Pharma brings together innovative life sciences and talent to meet the growing demand for high-quality drug manufacturing and therapies.